Pfizer (PFE) expect costs associated with multi-year cost realignment effort to continue through 2024 and to total about USD 2.8bln

08 May 2024 - 20:59- Equities- Source: Newswires

Pfizer IncPharmaceuticals, Biotechnology & Life SciencesPharmaceuticalsPharmaceuticals (Group)PFE.USPFEEquitiesS&P 500 IndexAsian SessionUS SessionUSDUnited States

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: